Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Omeros Corporation logo — Let science lead the way

Omeros Corporation

Let science lead the way

Founded 1994 United States Seattle, United States 234 employees Grant Total: $819.98M Biotechnology, Health Care +1

General Information

Company Name Omeros Corporation
Founded Year 1994
Location United States Seattle, United States +1
Founders / Decision Makers
Team member Team member
Employees 234
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

Get notified when Omeros Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Omeros Corporation

Omeros Corporation is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. Founded in 1994, the company operates in the industries of Biotechnology, Health Care, and Pharmaceutical from its headquarters in the United States. Omeros Corporation recently received a significant $6.69M grant investment on 10 April 2023 from the National Institute on Drug Abuse (NIDA). With its commitment to letting science lead the way, Omeros Corporation continues to show promise in the biopharmaceutical industry.

Taxonomy: biopharmaceutical, drug discovery, Seattle-based, small-molecule therapeutics, protein therapeutics, inflammation, coagulopathies, central nervous system disorders, orphan indications, science-driven, pharmaceutical industry, clinical trials, precision medicine

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
10 Apr 2023
Post-IPO Equity •••••• - 12 Aug 2020
Post-IPO Equity •••••• - 05 Dec 2019
Post-IPO Debt •••••• - 08 Nov 2018
Post-IPO Equity •••••• - 22 Aug 2017

View All 15 Funding Rounds

Latest News

View All
myTomorrows and Omeros Corporation Collaborate to Provide an Expanded Access Program for Narsoplimab — Dutchnews.nl
myTomorrows and Omeros Corporation Collaborate to Provide an Expanded Access Program for Narsoplimab
Dutchnews.nl Dec 18, 2019

Omeros Corporation Alternatives & Competitors

Omeros Corporation vs
HTL Biosolutions, Inc.
HTL Biosolutions, Inc. United States

Providing high quality research services. We have the know-how you need.

7 employees
Biopharma, Biotechnology
Compare Omeros Corporation vs HTL Biosolutions, Inc.
Omeros Corporation vs
Sciwind Biosciences
Sciwind Biosciences

Pioneering treatments to empower physicians in addressing metabolic disorders with advanced protein...

Series C
1 employees
Biotechnology, Health Care
Compare Omeros Corporation vs Sciwind Biosciences
Omeros Corporation vs
Elpis Biopharmaceuticals
Elpis Biopharmaceuticals United States

New Treatments. New Hope.

11 employees
Biotechnology
Also compare with: Omeros Corporation vs Gensun Biopharma Gensun Biopharma

FAQ About Omeros Corporation

Let science lead the way
Omeros Corporation was founded in 1994.
Omeros Corporation is headquartered in Seattle, United States.
Omeros Corporation operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Omeros Corporation has approximately 234 employees.
Omeros Corporation has completed 15 funding rounds, raising a total of $819.98M. The latest funding stage is Grant.
Top alternatives and competitors to Omeros Corporation include HTL Biosolutions, Inc., Sciwind Biosciences, Elpis Biopharmaceuticals, Gensun Biopharma, Output Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Omeros Corporation and HTL Biosolutions, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Omeros Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes